CN1285725C - Tissue engineered peripheral nerve graft - Google Patents
Tissue engineered peripheral nerve graft Download PDFInfo
- Publication number
- CN1285725C CN1285725C CN 200410027223 CN200410027223A CN1285725C CN 1285725 C CN1285725 C CN 1285725C CN 200410027223 CN200410027223 CN 200410027223 CN 200410027223 A CN200410027223 A CN 200410027223A CN 1285725 C CN1285725 C CN 1285725C
- Authority
- CN
- China
- Prior art keywords
- nerve
- cell
- microfilament
- peripheral nerve
- graft
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000578 peripheral nerve Anatomy 0.000 title claims abstract description 35
- 239000000463 material Substances 0.000 claims abstract description 58
- 210000003632 microfilament Anatomy 0.000 claims abstract description 55
- 102000002151 Microfilament Proteins Human genes 0.000 claims abstract description 54
- 108010040897 Microfilament Proteins Proteins 0.000 claims abstract description 54
- 210000004027 cell Anatomy 0.000 claims abstract description 48
- 210000001519 tissue Anatomy 0.000 claims abstract description 33
- 210000004116 schwann cell Anatomy 0.000 claims description 36
- 230000001537 neural effect Effects 0.000 claims description 20
- 230000015572 biosynthetic process Effects 0.000 claims description 17
- 210000000988 bone and bone Anatomy 0.000 claims description 17
- -1 poly(lactic acid) Polymers 0.000 claims description 15
- 238000006731 degradation reaction Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 230000021164 cell adhesion Effects 0.000 claims description 12
- 210000000130 stem cell Anatomy 0.000 claims description 12
- 230000015556 catabolic process Effects 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 7
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 7
- 210000002744 extracellular matrix Anatomy 0.000 claims description 7
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 229920000954 Polyglycolide Polymers 0.000 claims description 6
- 230000000763 evoking effect Effects 0.000 claims description 6
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 6
- 239000004633 polyglycolic acid Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 5
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 4
- 102000013275 Somatomedins Human genes 0.000 claims description 4
- 230000000975 bioactive effect Effects 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 210000005036 nerve Anatomy 0.000 abstract description 39
- 230000007547 defect Effects 0.000 abstract description 17
- 210000004126 nerve fiber Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 210000004504 adult stem cell Anatomy 0.000 abstract description 7
- 230000008929 regeneration Effects 0.000 abstract description 6
- 238000011069 regeneration method Methods 0.000 abstract description 6
- 238000000338 in vitro Methods 0.000 abstract description 4
- 239000011664 nicotinic acid Substances 0.000 abstract description 2
- 230000006698 induction Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000012010 growth Effects 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 230000008439 repair process Effects 0.000 description 11
- 108010083674 Myelin Proteins Proteins 0.000 description 5
- 102000006386 Myelin Proteins Human genes 0.000 description 5
- 210000001185 bone marrow Anatomy 0.000 description 5
- 230000005012 migration Effects 0.000 description 5
- 238000013508 migration Methods 0.000 description 5
- 210000005012 myelin Anatomy 0.000 description 5
- 210000000276 neural tube Anatomy 0.000 description 5
- 230000001172 regenerating effect Effects 0.000 description 5
- 208000010886 Peripheral nerve injury Diseases 0.000 description 4
- 210000003050 axon Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 230000007514 neuronal growth Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- MXNRLFUSFKVQSK-UHFFFAOYSA-N 2-Amino-6-(trimethylazaniumyl)hexanoate Chemical compound C[N+](C)(C)CCCCC(N)C([O-])=O MXNRLFUSFKVQSK-UHFFFAOYSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000028600 axonogenesis Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a tissue engineering peripheral nerve graft, which is a surgical graft for repairing nerve defects with wider application range and better quality. The tissue engineering peripheral nerve graft comprises a bracket for connecting two disconnected ends of a nerve and seed cells with the function of promoting nerve regeneration, wherein the seed cells are attached to the bracket to form a complex with a simulated nerve three-dimensional structure and bioactivity. The stent is a bundle-shaped microfilament structure which is made of biodegradable materials and consists of microfilaments, and the outer surface of the stent is coated with a film to form a tubular stent. The seed cell is a Schwann-like cell formed by in vitro induction of adult stem cells. The invention is a real tissue engineering peripheral nerve graft, which not only provides a bionic channel for the regenerated nerve fiber to pass through a nerve defect area, but also has the promotion effect of the seed cell in the nerve graft on nerve regeneration, thereby being used for repairing the nerve defect with longer distance, obviously improving the nerve repairing effect and having wider clinical application range.
Description
Technical field
The present invention relates to a kind of surgical implant, especially for the nerve graft of repairing peripheral nerve defection.
Background technology
The neurologic defect that causes after peripheral nerve injury and the damage is clinical common disabling condition.For the Repair of Peripheral Nerve Injury that causes because of various mishaies, be a difficult problem of neurosurgical treatment always.Annual newly-increased nearly 1,000,000 examples of case of China wherein, need be repaired about 450,000 examples of injured nerve by the implantable neural graft.At present, the source of nerve graft is very deficient, is badly in need of the neural surrogate of research and development.
Development to nerve graft both at home and abroad rests on the conduit of imitative neuromechanism always, people's chemical product of being developed at present is the tubular medical material that two broken ends of fractured bone with nerve couple together, promptly so-called " artificial neural tube " or " artificial nerve graft ".(patent No.: disclosed a kind of biological duct of being made by chitosan material 01108208.9), biological duct is embedded with fibrous framework, and the fibrous framework material is polyglycolic acid or poly(lactic acid) at Chinese patent " medical artificial nerve graft and preparation method thereof "; 00810000.4), " artificial neural tube " (application number: 99807035.1), " artificial neural canal " (application number: decompose the pipe that absorbing material forms in all having disclosed by organism 97199928.7) at Chinese patent application " artificial neural canal " (application number:, have the microfibre collastromin in its inner chamber, be filled with laminine in its space.
Above-mentioned currently available products all is the conduit made from the degradable biological material, can be at back " bridge joint " the damaged nerve that implants, but, the said products only is that the growth for the regenerating nerve aixs cylinder provides one " bridge " or " passage ", itself does not have biological activity, can not provide nerve growth necessary interior environment, also not promote the effect of neurotization.
Modern medicine is verified, and schwann cell has very important effect in the human nerve process of growth, and they adhere to and surround aixs cylinder formation myelin, promote the extension and the maturation of aixs cylinder.Because above-mentioned currently available products does not provide necessary schwann cell of neurotization or the active cells with similar functions, when the nearly broken ends of fractured bone grows newborn aixs cylinder, can only rely on related long simultaneously the coming of schwann cell of body itself, this process is just not only very slow, and the migration of the schwann cell of body itself has certain limit, if schwann cell advances not go, perhaps advance seldom, neural growth just is greatly affected, if be applied to clinically, only can repair short-range neurologic defect, generally be no more than 15 millimeters, often can directly sew up short-range neurologic defect like this clinically, and need be by these nerve grafts.To the neurologic defect of longer distance, even " bridge joint " above-mentioned conduit, the regenerated neural axon can not arrive the broken ends of fractured bone far away, can not recover the function of injured nerve, thereby repairing effect is very undesirable.
In recent years, the reparation that appears as tissue injury of organizational engineering has brought new hope.Organizational engineering is the principle and the method for application engineering and life science, research normal and the mammalian tissues form of pathology and the mutual relationship of function, the science of the biological substitution thing of exploitation damaged tissue repair form and function is the important content of biological technical field.Be to utilize bionic principle specifically, preparation has specific three-dimensional structure and bioactive complex body, builds the tissue of normal physiological function, can be used for substituting the form and function of human body defective tissue.The appearance of organizational engineering indicates that medical science will enter the new stage with made tissue and organ transplantation repair deficiency and reconstruction function from existing pattern from body or allosome tissue and organ transplantation.
Above-mentioned currently available products does not have biological activity, is not tissue engineered peripheral nerve graft truly, and this is to cause currently available products unfavorable basic reason of effect in nerve is repaired.
Summary of the invention
The object of the present invention is to provide a kind of tissue engineered peripheral nerve graft, be used to repair the neurologic defect that occurs after the peripheral nerve injury.
Tissue engineered peripheral nerve graft of the present invention, comprise and be used to connect the support of neural two broken ends of fractured bone and have the seed cell that promotes the neurotization function, seed cell is attached on the support, forms to have imitative neural three-dimensional structure and bioactive complex body.
Described support is the pencil microfilament structure of being made up of microfilament of biodegradable material preparation, and its outside surface coats skim, the formation tubular bracket.
The biodegradable material that is used to prepare support can be the synthesis and degradation material, perhaps natural biological degradable material, the perhaps material of both combined preparation.Described synthesis and degradation material is selected from one or more combination of poly(lactic acid), polyglycolic acid, polycaprolactone and multipolymer thereof; Described natural biological degradable material is selected from one or more combination of collagen, chitosan, Lalgine.
Be the further adhesivity that strengthens support to seed cell, and promote the vascularization process of neurotization and graft, described microfilament surface can scribble the material that can promote cell adhesion, neurotization and graft vascularization.
Another program is in the preparation of microfilament, makes to contain the material that can promote cell adhesion, neurotization and graft vascularization in the microfilament, and this material can discharge in the microfilament degradation process gradually.
The above-mentioned material that can promote cell adhesion, neurotization and graft vascularization can (extracellular matrix ECM), comprises collagen, aminoglycan, glycoprotein three major types for extracellular matrix; Also can be various somatomedins.
The diameter of described microfilament is 5～50 μ m.Be preferably 10～20 μ m.According to the required diameter of repairing nerve of patient, select for use by the microfilament of suitable diameter and suitable quantity and form pencil microfilament structure, both can be seed cell competent attachment site was provided, do not hinder growing into of regenerating nerve aixs cylinder again.
Described film can be semi-permeable membranes.This film can allow nutritive ingredient such as oxygen molecule, protein, carbohydrate etc. enter in the film, and the degraded product that makes tissue metabolism's refuse in the film and microfilament is discharged outside the film, stop growing into of the interior fibrillar connective tissue of body simultaneously, avoid detrimentally affect neurotization.
Described film also can be the film of biodegradable material preparation.Described biodegradable material can be the synthesis and degradation material, perhaps natural biological degradable material, the perhaps material of both combined preparation.Described synthesis and degradation material is selected from one or more combination of poly(lactic acid), polyglycolic acid, pla-pcl and multipolymer thereof; Described natural biological degradable material is selected from one or more combination of collagen, chitosan, Lalgine.This film is the porous-film with certain permeability, the aperture is preferably 5～25 μ m, can allow nutritive ingredient such as oxygen molecule, protein, carbohydrate etc. enter in the film, and the degraded product that makes tissue metabolism's refuse in the film and microfilament is discharged outside the film, stop growing into of the interior fibrillar connective tissue of body simultaneously, avoid detrimentally affect neurotization.
Described seed cell is through the external evoked class schwann cell that forms by adult stem cell.Adult stem cell is preferably bone marrow interstital stem cell, perhaps fat stem cell.
Peripheral nerve is made up of neurocyte, schwann cell, reticular tissue, blood vessel, lymphatic vessel and special sustenticular cell.Neurocyte (neurone) is again that the cytoplasmic process by cell space part and projection constitutes, and the end of cytoplasmic process contacts with neurone after the branch repeatedly, and aixs cylinder is one of them the longest and most important cytoplasmic process, and is stretchable to effector.Schwann cell holds aixs cylinder and forms nerve fiber.Up to ten thousand fiber concentrates in together the formation nerve tract, and one or several nerve tracts are linked together by reticular tissue, have just formed peripheral nerve.When peripheral nerve fracture and occur damaged after, need come " bridge joint " damaged nerve segment with graft, newborn neural axon is from the nearly broken ends of fractured bone graft of growing into, under the guiding of schwann cell to broken ends of fractured bone growth far away.Modern medicine is verified, and schwann cell has important role in the human nerve process of growth, and they adhere to and surround aixs cylinder formation myelin, promote the extension and the maturation of aixs cylinder.The contriver successfully with adult stem cell in vitro culture by drug-induced for having the cell of schwann cell form and functional character, called after " class schwann cell ", these cells should be that human peripheral nerve injury is repaired one of cell the most suitable in the designed seed cell that engineered nerve adopted, and road has been paved in the regeneration that its propagation in vivo is neural axon.
Existing what is called " artificial neural tube " or " artificial nerve graft " only are " bridges " or " passage " that the growth for the regenerating nerve aixs cylinder provides, and tissue engineered peripheral nerve graft of the present invention has breakthrough advantage, promptly adopted the seed cell that " plantation " has biologic activity on the support that connects the neural broken ends of fractured bone, this seed cell is through external evoked " the class schwann cell " with schwann cell (Schwann ' s cells) form and functional character that forms by adult stem cell, cell has the characteristic of the growth of attaching, the class schwann cell can adhere at rack surface, migration, propagation, formation has the artificial nervous tissue of special three-dimensional structure and active cells.Support and seed cell all are the requisite integral parts of peripheral nerve graft of the present invention, have constituted tissue engineered peripheral nerve graft truly thus.
The present invention is when using, and with the neurologic defect position of described tissue engineered peripheral nerve graft implant into body, the newborn aixs cylinder that grows from the neural broken ends of fractured bone begins in the progress support and extension and ripe in support.In this process, the seed cell that is attached on the support is then constantly bred, is moved by the direction of growth of regeneration aixs cylinder, form the cell band of " class schwann cell ", waiting the arrival of newborn aixs cylinder, in the process of newborn neural axon growth, seed cell is equivalent to " guide " of " meeting " newborn aixs cylinder, and necessary trophism and inducing action is provided.Newborn peripheral nerve aixs cylinder just have one by one class schwann cell go " meeting " it, and surround aixs cylinder, form myelin, and make it to reach the maturation on the function.Simultaneously,, abdicate space, and finally replaced also in continuous degraded by the support of biodegradable material preparation by new life's nerve fiber to the nerve fiber growth.The vivo degradation speed of support and the speed of growth of nerve fiber are complementary, and avoid causing card to press to nerve fiber.Film with the semi-permeable membranes preparation also can be absorbed fully by body.
Because the peripheral nerve growth necessarily needs schwann cell " escorting ".Existing nerve graft product only provides support and the active cells that schwann cell is not provided or has similar functions, when the nearly broken ends of fractured bone grows newborn aixs cylinder, can only rely on related long simultaneously the coming of schwann cell of body itself, this process is just not only very slow, and the migration of the schwann cell of body itself has certain limit, if schwann cell advances not go, perhaps advance seldom, neural growth just is greatly affected, if be applied to clinically, only can repair short-range neurologic defect, generally be no more than 15 millimeters, often can directly sew up short-range neurologic defect like this clinically, and need be by these nerve grafts.As the neurologic defect more than 3 centimetres, even " bridge joint " above-mentioned conduit, the regenerated neural axon can not arrive the broken ends of fractured bone far away, is difficult to recover the function of injured nerve, thereby repairing effect is very undesirable to longer distance.And the present invention adopts seed cell and support structure combining, the passage of imitation biochemistry not only is provided by the neurologic defect district for the regenerated nerve fiber, and its intrinsic seed cell has promoter action to neurotization, therefore can be used for repairing the neurologic defect of longer distance, neural repairing effect significantly improves, and clinical application range is wider.
Description of drawings
Fig. 1 is a structural representation of the present invention.
Fig. 2 is the A-A diagrammatic cross-section of Fig. 1.
Fig. 3 is the enlarged diagram at B position among Fig. 2.
Fig. 4 is the enlarged diagram at C position among Fig. 1.
Fig. 5 is an application synoptic diagram of the present invention.
Embodiment
Tissue engineered peripheral nerve graft of the present invention, as shown in Figure 1 to Figure 3, comprise and be used to connect the support 1 of neural two broken ends of fractured bone and have the seed cell 2 that promotes the neurotization function, seed cell 2 is attached on the support 1, forms to have imitative neural three-dimensional structure and bioactive complex body.Support 1 is the pencil microfilament structure of being made up of microfilament 13 11 of biodegradable material preparation, and its outside surface coats skim 12, the formation tubular bracket.As shown in Figure 4, seed cell 2 mainly is attached to microfilament 13 surfaces.In actual product, seed cell 2 also can be attached to other positions of support 1, on film 12.As shown in Figure 5, when repairing neurologic defect, tissue engineered peripheral nerve graft of the present invention is implanted between the nearly broken ends of fractured bone 3 and the broken ends of fractured bone 4 far away.
In actual product, the microfilament that pencil microfilament structure is contained is minimum, and Fig. 1 to Fig. 5 is the microcosmic synoptic diagram, and its ratio is not represented the ratio of actual product.
Described seed cell is through the external evoked class schwann cell that forms by adult stem cell.Adult stem cell includes multiple stem cell, and as bone marrow interstital stem cell, fat stem cell etc., following examples are to be illustrated as seed cell respectively through external evoked bone marrow interstital stem cell and fat stem cell:
Embodiment one:
Adopt biodegradable material to be prepared into microfilament 13, and be assembled into pencil microfilament structure 11, prepare film forming 12 with biodegradable material or semi-permeable membranes in addition, film 12 is coated pencil microfilament structure 11 form support 1, the sterilization back is standby.In patient's body (as ilium, shin bone) extracts marrow, isolate bone marrow interstital stem cell, in the external cell cultures of carrying out, add inductor (as all-trans retinoic acid, mercaptoethanol, Prostatropin, platelet-derived growth factor etc.) make it be divided into the class schwann cell, be planted in pencil microfilament structure 11 sterilization after on as seed cell 2 above-mentioned cell then and continue in vitro culture, these cells are evenly distributed on the pencil microfilament structure 11, coat pencil microfilament structure 11 with film 12 at last, form tubular structure, promptly obtained of the present invention by tissue engineered peripheral nerve graft through external evoked bone marrow interstital stem cell and biodegradable material structure.During clinical use, tissue engineered peripheral nerve graft of the present invention is implanted to the peripheral nerve defection place that will repair, the class schwann cell on the support is along direction of growth propagation, the migration of regeneration aixs cylinder.After the peripheral nerve fracture, newborn aixs cylinder is longer from the nearly broken ends of fractured bone 3 of nerve, and near the class schwann cell, the class schwann cell surrounds aixs cylinder, forms myelin, provides nutrition to aixs cylinder, and the neurophilic far-end growth of guiding aixs cylinder, is connected with the broken ends of fractured bone far away 4 of nerve fiber.In this process, the function of class schwann cell performance schwann cell, support 1 is then constantly being degraded or is being absorbed by body, and the nerve fiber that finally is reproduced replaces.
In the present embodiment, described biodegradable material is by the synthesis and degradation material, perhaps natural biological degradable material, and perhaps both composition materials are prepared from.Described synthesis and degradation material is selected from one or more combination of poly(lactic acid), polyglycolic acid, pla-pcl and multipolymer thereof.Described natural biological degradable material is selected from one or more combination of collagen, chitosan, Lalgine.
In the present embodiment,, select for use by the microfilament of suitable diameter and suitable quantity and form pencil microfilament structure, so both can be seed cell competent attachment site is provided, do not hinder growing into of regenerating nerve aixs cylinder again according to the required diameter of repairing nerve of patient.
The present invention is when using, and selected microfilament diameter is irrelevant with the neural diameter of repair, but decides number and the length of forming the required microfilament of pencil microfilament structure according to the length of repair neural diameter and neurologic defect.The diameter of microfilament is typically designed to 5～50 μ m.
Be the further adhesivity that strengthens support to seed cell, and promote the vascularization process of neurotization and graft, the microfilament surface described in the present embodiment can scribble the material that can promote cell adhesion, neurotization and graft vascularization.
In the present embodiment, also can make and contain the material that can promote cell adhesion, neurotization and graft vascularization in the microfilament in the preparation of microfilament, this material can discharge in the microfilament degradation process gradually.
The above-mentioned material that can promote cell adhesion, neurotization and graft vascularization can (extracellular matrix ECM), comprises collagen, aminoglycan, glycoprotein three major types for extracellular matrix; Also can be various somatomedins.
Embodiment two:
Adopt biodegradable material to be prepared into microfilament 13, and be assembled into pencil microfilament structure 11, prepare film forming 12 with biodegradable material or semi-permeable membranes in addition, film 12 is coated pencil microfilament structure 11 form support 1, the sterilization back is standby.Extract fatty tissue in abundant place (as stomach wall) at patient's body fat, the separating out fat stem cell, in the external cell cultures of carrying out, add inductor (as Prostatropin, nerve growth factor etc.) make it be divided into the class schwann cell, plant pencil microfilament structure 11 sterilization after on as 2 kinds of seed cells above-mentioned cell then and continue in vitro culture, these cells are evenly distributed on the pencil microfilament structure 11, coat pencil microfilament structure 11 with film 12 at last, form tubular structure, promptly obtained of the present invention by tissue engineered peripheral nerve graft through inductive fat stem cell and biodegradable material structure.During clinical use, tissue engineered peripheral nerve graft of the present invention is implanted to the peripheral nerve defection place that will repair, the class schwann cell on the support is along direction of growth propagation, the migration of regeneration aixs cylinder.After the peripheral nerve fracture, newborn aixs cylinder is longer from the nearly broken ends of fractured bone 3 of nerve, and near the class schwann cell, the class schwann cell surrounds aixs cylinder, forms myelin, provides nutrition to aixs cylinder, and the neurophilic far-end growth of guiding aixs cylinder, is connected with the broken ends of fractured bone far away 4 of nerve fiber.In this process, the function of class schwann cell performance schwann cell, support 1 is then constantly being degraded or is being absorbed by body, and the nerve fiber that finally is reproduced replaces.
In the present embodiment, described biodegradable material is by the synthesis and degradation material, perhaps natural biological degradable material, and perhaps both composition materials are prepared from.Described synthesis and degradation material is selected from one or more combination of poly(lactic acid), polyglycolic acid, pla-pcl and multipolymer thereof.Described natural biological degradable material is selected from one or more combination of collagen, chitosan, Lalgine.
In the present embodiment,, select for use by the microfilament of suitable diameter and suitable quantity and form pencil microfilament structure, so both can be seed cell competent attachment site is provided, do not hinder growing into of regenerating nerve aixs cylinder again according to the required diameter of repairing nerve of patient.
The present invention is when using, and selected microfilament diameter is irrelevant with the neural diameter of repair, but decides number and the length of forming the required microfilament of pencil microfilament structure according to the length of repair neural diameter and neurologic defect.The diameter of microfilament is typically designed to 5～50 μ m.
Be the further adhesivity that strengthens support to seed cell, and promote the vascularization process of neurotization and graft, the microfilament surface described in the present embodiment can scribble the material that can promote cell adhesion, neurotization and graft vascularization.
In the present embodiment, also can make and contain the material that can promote cell adhesion, neurotization and graft vascularization in the microfilament in the preparation of microfilament, this material can discharge in the microfilament degradation process gradually.
The above-mentioned material that can promote cell adhesion, neurotization and graft vascularization can (extracellular matrix ECM), comprises collagen, aminoglycan, glycoprotein three major types for extracellular matrix; Also can be various somatomedins.
Above-listed detailed description is at the specifying of possible embodiments of the present invention, but this embodiment is not in order to limiting claim of the present invention, does not allly break away from the equivalence that spirit of the present invention does and implements or change, all should be contained in the claim of the present invention.
Claims (7)
1, tissue engineered peripheral nerve graft, comprise the support (1) that is used to connect neural two broken ends of fractured bone and have the seed cell (2) that promotes the neurotization function, seed cell (2) is attached on the support (1), formation has imitative neural three-dimensional structure and bioactive complex body, it is characterized in that: described support (1) is the pencil microfilament structure of being made up of microfilament (13) (11) of biodegradable material preparation, its outside surface coats a skim (12), forms tubular bracket; Described seed cell (2) is the external evoked class schwann cell that forms of fat stem cell.
2, tissue engineered peripheral nerve graft according to claim 1, it is characterized in that: described microfilament (13) surface scribbles the material that can promote cell adhesion, neurotization and graft vascularization, perhaps contains the material that can promote cell adhesion, neurotization and graft vascularization in the microfilament (13).
3, tissue engineered peripheral nerve graft according to claim 2 is characterized in that: describedly can promote that the material of cell adhesion, neurotization and graft vascularization is extracellular matrix or somatomedin.
4, tissue engineered peripheral nerve graft according to claim 1 is characterized in that: the diameter of described microfilament (13) is 5～50 μ m.
5, tissue engineered peripheral nerve graft according to claim 1 is characterized in that: described film (12) is a semi-permeable membranes, perhaps the film for preparing for biodegradable material.
6, tissue engineered peripheral nerve graft according to claim 1 or 5, it is characterized in that: described biodegradable material is the synthesis and degradation material, perhaps natural biological degradable material, the perhaps material of both combined preparation.
7, tissue engineered peripheral nerve graft according to claim 6 is characterized in that: described synthesis and degradation material is selected from one or more combination of poly(lactic acid), polyglycolic acid, polycaprolactone and multipolymer thereof; Described natural biological degradable material is selected from one or more combination of collagen, chitosan, Lalgine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410027223 CN1285725C (en) | 2004-05-18 | 2004-05-18 | Tissue engineered peripheral nerve graft |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410027223 CN1285725C (en) | 2004-05-18 | 2004-05-18 | Tissue engineered peripheral nerve graft |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1580255A CN1580255A (en) | 2005-02-16 |
| CN1285725C true CN1285725C (en) | 2006-11-22 |
Family
ID=34582018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410027223 Expired - Fee Related CN1285725C (en) | 2004-05-18 | 2004-05-18 | Tissue engineered peripheral nerve graft |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1285725C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111544648A (en) * | 2020-05-14 | 2020-08-18 | 南通大学 | A protein-modified PLGA microsphere and its tissue engineered nerve |
| US11788058B2 (en) | 2020-05-14 | 2023-10-17 | Nantong University | Protein-modified PLGA microsphere and tissue-engineered nerve constructed therewith |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2347539C1 (en) * | 2008-01-09 | 2009-02-27 | Игорь Викторович Балязин | Method for treatment of peripheral nerve damage |
| RU2376650C1 (en) * | 2008-07-21 | 2009-12-20 | Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" | Method of directional regeneration of muscular rami of facial nerve in experiment |
| JP6155188B2 (en) * | 2010-04-12 | 2017-06-28 | スパイバー テクノロジーズ アーベーＳｐｉｂｅｒ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ａｂ | Methods and combinations |
| RU2446757C1 (en) * | 2010-08-13 | 2012-04-10 | Федеральное государственное учреждение "Российский ордена Трудового Красного Знамени научно-исследовательский институт травматологии и ортопедии им.Р.Р.Вредена Министерства Здравоохранения и социального развития Российской Федерации" (ФГУ "РНИИТО им.Р.Р.Вредена Минздравсоцразвития России") | Method of isolating area of peripheral nerve suture with application of polytetrofluorethylene |
| RU2525635C2 (en) * | 2011-05-31 | 2014-08-20 | Салават Ахметнурович Исламов | Method for surgical management of sudeck atrophy |
| CN110227184B (en) * | 2019-07-16 | 2020-04-24 | 南通大学 | Differential tissue engineered nerves and applications |
| CN110507857B (en) * | 2019-08-30 | 2021-01-29 | 江南大学 | A kind of tissue engineered nerve graft and preparation method thereof |
| US20240189483A1 (en) * | 2019-11-01 | 2024-06-13 | Allegro 3D, Inc. | 3d-bioprinted scaffolds for tissue regeneration |
| RU2768595C1 (en) * | 2021-04-13 | 2022-03-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" | Method of repairing injured peripheral nerve |
| CN115607732B (en) * | 2022-10-18 | 2023-10-20 | 尧舜泽生物医药(南京)有限公司 | Bionic nerve graft and preparation method thereof |
| CN115944784B (en) * | 2023-01-04 | 2024-12-03 | 南通大学 | Cell fiber scaffold and preparation method and application thereof |
-
2004
- 2004-05-18 CN CN 200410027223 patent/CN1285725C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111544648A (en) * | 2020-05-14 | 2020-08-18 | 南通大学 | A protein-modified PLGA microsphere and its tissue engineered nerve |
| US11788058B2 (en) | 2020-05-14 | 2023-10-17 | Nantong University | Protein-modified PLGA microsphere and tissue-engineered nerve constructed therewith |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1580255A (en) | 2005-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fornasari et al. | Natural-based biomaterials for peripheral nerve injury repair | |
| US9675646B2 (en) | Tubular bioengineered smooth muscle structures | |
| US5904716A (en) | Method for reconstituting cartilage tissue using demineralized bone and product thereof | |
| CN105705172B (en) | Hydrophilic electrostatic spinning biological composite scaffold material for tissue regeneration and preparation method and application thereof | |
| US8663675B2 (en) | Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction | |
| CN1285725C (en) | Tissue engineered peripheral nerve graft | |
| US11801331B2 (en) | Composition for cartilage regeneration and preparing thereof | |
| EP1242129A2 (en) | Biological joint construct | |
| WO2005011765A1 (en) | Method of constructing artificial joint | |
| DE60129850T2 (en) | REPLACEMENT FOR COMPOUND WOVENS, METHOD FOR THE PRODUCTION AND USE THEREOF | |
| WO2010118874A2 (en) | Implant and therapeutic composition for treating damage and/or diseases relating to the human and/or animal musculoskeletal system | |
| CN1258591C (en) | Tissue engineered peripheral nerve graft | |
| KR100488405B1 (en) | Bio-resorbable nerve conduit and method for preparing the same | |
| CN2797374Y (en) | tissue engineered peripheral nerve graft | |
| CN1280411C (en) | Tissue engineered peripheral nerve graft | |
| JP3839777B2 (en) | Use of a biological material containing a three-dimensional skeleton of a hyaluronic acid derivative for preparing a graft in arthroscopy, and an instrument kit for transplanting said biological material by arthroscopy | |
| CN116510065B (en) | Recombinant humanized type III collagen hemostatic sponge and its application | |
| CN101062429A (en) | Method for constructing tissue engineering double-layered skin and the application thereof | |
| CN113017944A (en) | Artificial blood vessel stent with bioactivity, preparation method and application thereof | |
| CN2830410Y (en) | tissue engineered peripheral nerve graft | |
| CN2705462Y (en) | tissue engineered peripheral nerve graft | |
| CN2830409Y (en) | tissue engineered peripheral nerve graft | |
| CN116514956A (en) | Recombinant humanized III type collagen and application thereof | |
| AU2002219226A1 (en) | Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological materials by arthroscopy | |
| CN1281745C (en) | Tissue engineered peripheral nerve graft |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061122 Termination date: 20150518 |
|
| EXPY | Termination of patent right or utility model |